The University of Queensland

Prostate cancer part one: detection

Gardiner, R. A., Chambers, S. K., Williams, S. G., Yaxley, J., Samaratunga, H. and Frydenberg, M. (2014). Prostate cancer part one: detection. Endotext. (pp. ---) Massachusetts, United States of America: MDTEXT.COM.

The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study

Franklin, Anthony, Gianduzzo, Troy, Kua, Boon, Wong, David, McEwan, Louise, Walters, James, Esler, Rachel, Roberts, Matthew J., Coughlin, Geoff and Yaxley, John W. (2024). The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study. Asian Journal of Urology, 11 (1), 33-41. doi: 10.1016/j.ajur.2023.01.007

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

Vis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

Pathmanathan, Shivanshan, Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C., Gan, Chun Loo and Roberts, Matthew J. (2023). Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. European Journal of Nuclear Medicine and Molecular Imaging, 51 (1), 295-303. doi: 10.1007/s00259-023-06380-4

Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework

Patel, Nishal, Mehawed, Georges, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Chung, Eric, Tse, Vincent and Roberts, Matthew J. (2023). Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework. Urology, 178, 1-8. doi: 10.1016/j.urology.2023.05.002

Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging

Samaratunga, Hemamali, Egevad, Lars, Yaxley, John W., Johannsen, Shulammite, Le Fevre, Ian K., Perry-Keene, Joanna L., Gianduzzo, Troy, Chabert, Charles, Coughlin, Gregory, Parkinson, Robert, Kua, Boon, Yaxley, William and Delahunt, Brett (2023). Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging. American Journal of Surgical Pathology, 47 (6), 701-708. doi: 10.1097/pas.0000000000002042

Focal irreversible electroporation for treatment of primary and radio-recurrent prostate cancer – the evidence is mounting!

Yaxley, John W. (2023). Focal irreversible electroporation for treatment of primary and radio-recurrent prostate cancer – the evidence is mounting!. BJU International, 131 (S4), 32-33. doi: 10.1111/bju.15987

LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia

Samaratunga, Hemamali, Egevad, Lars, Thunders, Michelle, Iczskowski, Kenneth A., van der Kwast, Theodorus, Kristiansen, Glen, Pan, Chin-Chen, Leite, Katia R.M., Evans, Andrew, Clouston, David, Kenwright, Diane N., Bethwaite, Peter B., Malone, Greg, Wood, Simon, Yaxley, John W. and Delahunt, Brett (2022). LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia. Pathology, 54 (7), 842-847. doi: 10.1016/j.pathol.2022.09.002

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

Ong, Sean, Chen, Kenneth, Grummet, Jeremy, Yaxley, John, Scheltema, Matthijs J., Stricker, Phillip, Tay, Kae Jack and Lawrentschuk, Nathan (2022). Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?. BJU International, 131 (1), 20-31. doi: 10.1111/bju.15883

Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)

Tariq, Arsalan, McGeorge, Stephen, Pearce, Adam, Rhee, Handoo, Wood, Simon, Kyle, Samuel, Marsh, Philip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2022). Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT). Urologic Oncology: Seminars and Original Investigations, 40 (6), 276.e1-276.e9. doi: 10.1016/j.urolonc.2022.03.007

Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study

Yaxley, William John, Gianduzzo, Troy, Kua, Boon, Oxford, Rachel and Yaxley, John William (2022). Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study. Investigative and Clinical Urology, 63 (3), 285-293. doi: 10.4111/icu.20210472

Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy

Yaxley, William, Delahunt, Brett, Yaxley, John, Thunders, Michelle C., Kenwright, Diane N., Egevad, Lars and Samaratunga, Hemamali (2022). Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy. Pathology, 54 (6), 694-699. doi: 10.1016/j.pathol.2022.02.009

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

Roberts, Matthew J., Morton, Andrew, Papa, Nathan, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Brown, Nicholas, Parkinson, Robert, Emmett, Louise and Yaxley, John W. (2022). Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging, 49 (9), 3289-3294. doi: 10.1007/s00259-022-05756-2

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

Raveenthiran, S., Yaxley, W. J., Franklin, T., Coughlin, G., Roberts, M., Gianduzzo, T., Kua, B., Samaratunga, H., Delahunt, B., Egevad, L., Wong, D., McEwan, L., Brown, N., Parkinson, R., Esler, R. and Yaxley, J. W. (2022). Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer. Journal of Urology, 207 (3), 573-580. doi: 10.1097/JU.0000000000002293

The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison

Tariq, Arsalan, Kwok, Michael, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Marsh, Phillip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2022). The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison. Urologic Oncology: Seminars and Original Investigations, 40 (2), 66.e1-66.e9. doi: 10.1016/j.urolonc.2021.11.006

Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis

Kwok, Michael, Yaxley, William, Ranasinghe, Sachinka, Morton, Leanne, Perera, Sachin, Ponen, Kreyen, Pelecanos, Anita, Britton, Sumudu, Harris, Patrick N. A., Paterson, David L., Esler, Rachel, Hussey, David, Yaxley, John W. and Roberts, Matthew J. (2022). Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis. Journal of Clinical Urology, 205141582210998. doi: 10.1177/20514158221099856

Intraductal carcinoma of the prostate: extreme nuclear size is not a diagnostic parameter

Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John W., Johannsen, Shulammite and Egevad, Lars (2021). Intraductal carcinoma of the prostate: extreme nuclear size is not a diagnostic parameter. American Journal of Surgical Pathology, 45 (11), 1527-1533. doi: 10.1097/PAS.0000000000001776

Should lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?

Yaxley, William John, McBean, Rhiannon, Wong, David, Grimes, David, Vasey, Paul, Frydenberg, Mark and Yaxley, John William (2021). Should lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?. Investigative and Clinical Urology, 62 (6), 650-657. doi: 10.4111/icu.20210097

Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications

Tariq, Arsalan, McCart Reed, Amy E., Morton, Andrew, Porten, Sima, Vela, Ian, Williams, Elizabeth D., Yaxley, John W., Black, Peter C. and Roberts, Matthew J. (2021). Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications. European Urology Focus, 8 (5), 1256-1269. doi: 10.1016/j.euf.2021.07.016

Dual-tracer positron-emission tomography using prostate-specific membrane antigen and fluorodeoxyglucose for staging of prostate cancer: a systematic review

McGeorge, Stephen, Kwok, Michael, Jiang, Andrew, Emmett, Louise, Pattison, David A., Thomas, Paul A., Yaxley, John W. and Roberts, Matthew J. (2021). Dual-tracer positron-emission tomography using prostate-specific membrane antigen and fluorodeoxyglucose for staging of prostate cancer: a systematic review. Advances in Urology, 2021 1544208, 1544208. doi: 10.1155/2021/1544208

Letter to the Editor BJUI in response to Montorsi et al.: Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer

Yaxley, John (2021). Letter to the Editor BJUI in response to Montorsi et al.: Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer. BJU International, 127 (6), 747-747. doi: 10.1111/bju.15377

Level 1 evidence of better early urinary continence at 3 months following robot-assisted laparoscopic radical prostatectomy compared with laparoscopic radical prostatectomy: results of the LAP-01 randomised controlled trial

Yaxley, John W., Coughlin, Geoff and Patel, Vipul (2021). Level 1 evidence of better early urinary continence at 3 months following robot-assisted laparoscopic radical prostatectomy compared with laparoscopic radical prostatectomy: results of the LAP-01 randomised controlled trial. European Urology, 79 (6), 760-761. doi: 10.1016/j.eururo.2021.02.039

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): Protocol of a phase II randomised controlled trial

Nair-Shalliker, Visalini, Smith, David P., Gebski, Val, Patel, Manish I., Frydenberg, Mark, Yaxley, John W., Gardiner, Robert, Espinoza, David, Kimlin, Michael G., Fenech, Michael, Gillatt, David, Woo, Henry, Armstrong, Bruce K., Rasiah, Krishan, Awad, Nader, Symons, James and Gurney, Howard (2021). High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): Protocol of a phase II randomised controlled trial. BMJ Open, 11 (3) e044055, 1-9. doi: 10.1136/bmjopen-2020-044055

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Roberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2021). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 477-482. doi: 10.1007/s00259-020-04944-2

External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study

Meijer, Dennie, van Leeuwen, Pim J., Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and Vis, André N. (2021). External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study. European Urology, 80 (2), 234-242. doi: 10.1016/j.eururo.2021.05.006

Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer

Franklin, Anthony, Yaxley, William J., Raveenthiran, Sheliyan, Coughlin, Geoff, Gianduzzo, Troy, Kua, Boon, McEwan, Lousie, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hema, Brown, Nicholas, Parkinson, Rob, Roberts, Matthew J. and Yaxley, John W. (2021). Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer. BJU International, 127 (1), 71-79. doi: 10.1111/bju.15134

Intraductal carcinoma of the prostate is not a diagnostic entity

Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Srigley, John R., Cheng, Liang, Clouston, David, Furusato, Bungo, Kench, James, Leite, Katia R. M., MacLennan, Gregory T., Moch, Holger, Pan, Chin-Chen, Ro, Jae, Tsuzuki, Toyonori, van der Kwast, Theodorus, Wheeler, Thomas and Yaxley, John W. (2021). Intraductal carcinoma of the prostate is not a diagnostic entity. Histopathology, 78 (2), 342-344. doi: 10.1111/his.14260

Open retropubic radical prostatectomy

Pereira, Ryan, Joshi, Andre, Roberts, Matthew, Yaxley, John and Vela, Ian (2020). Open retropubic radical prostatectomy. Translational Andrology and Urology, 9 (6), 3025-3035. doi: 10.21037/tau.2019.09.15

Understanding the diagnosis of prostate cancer

Ong, Xuan Rui S., Bagguley, Dominic, Yaxley, John W., Azad, Arun A., Murphy, Declan G. and Lawrentschuk, Nathan (2020). Understanding the diagnosis of prostate cancer. Medical Journal of Australia, 213 (9), 424-429. doi: 10.5694/mja2.50820

Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications

Yaxley, William John, Nouhaud, François-Xavier, Raveenthiran, Sheliyan, Franklin, Anthony, Donato, Peter, Coughlin, Geoff, Kua, Boon, Gianduzzo, Troy, Wong, David, Parkinson, Robert, Brown, Nicholas, Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Roberts, Matthew and Yaxley, John William (2020). Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications. Prostate Cancer and Prostatic Diseases, 24 (2), 398-405. doi: 10.1038/s41391-020-00289-x

Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution

Roberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Roberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2020). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 655-656. doi: 10.1007/s00259-020-04944-2

Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data: managing BPH in the 21st century

Morton, Andrew, Williams, Michael, Perera, Marlon, Teloken, Patrick E., Donato, Peter, Ranasinghe, Sachinka, Chung, Eric, Bolton, Damien, Yaxley, John and Roberts, Matthew J. (2020). Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data: managing BPH in the 21st century. BJU International, 126 Suppl 1 (S1), 18-26. doi: 10.1111/bju.15098

Granular necrosis: a distinctive form of cell death in malignant tumours

Samaratunga, Hemamali, Delahunt, Brett, Srigley, John R., Berney, Daniel M., Cheng, Liang, Evans, Andrew, Furusato, Bungo, Leite, Katia R. M., MacLennan, Gregory T., Martignoni, Guido, Moch, Holger, Pan, Chin-Chen, Paner, Gladell, Ro, Jae, Thunders, Michelle, Tsuzuki, Toyonori, Wheeler, Thomas, van der Kwast, Theodorus, Varma, Murali, Williamson, Sean R., Yaxley, John W. and Egevad, Lars (2020). Granular necrosis: a distinctive form of cell death in malignant tumours. Pathology, 52 (5), 507-514. doi: 10.1016/j.pathol.2020.06.002

Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: national population data over 15 years

Roberts, Matthew J., Papa, Nathan, Perera, Marlon, Joshi, Andre, Scott, Susan, Bolton, Damien, Lawrentschuk, Nathan and Yaxley, John (2020). Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: national population data over 15 years. Asia-Pacific Journal of Clinical Oncology, 16 (2) ajco.13158, e118-e124. doi: 10.1111/ajco.13158

68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

Donato, Peter, Morton, Andrew, Yaxley, John, Ranasinghe, Sachinka, Teloken, Patrick E., Kyle, Samuel, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A. and Roberts, Matthew J. (2020). 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?. European Journal of Nuclear Medicine and Molecular Imaging, 47 (8), 1843-1851. doi: 10.1007/s00259-019-04620-0

Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?

Chen, Michael Y., Franklin, Anthony, Yaxley, John, Gianduzzo, Troy, McBean, Rhiannon, Wong, David, Tatkovic, Annaleis, McEwan, Louise, Walters, James and Kua, Boon (2020). Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?. BJU International, 126 (3), 396-401. doi: 10.1111/bju.15152

Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy

Franklin, Anthony, Gianduzzo, Tony, Yaxley, John, Kua, Boon, Coughlin, Geoff, Samaratunga, Hema and Gianduzzo, Troy (2020). Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy. BJU International, 126 (S1), 6-11. doi: 10.1111/bju.14974

Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group

Lieng, Hester, Kneebone, Andrew, Hayden, Amy J., Christie, David R.H., Davis, Brian J., Eade, Thomas N., Emmett, Louise, Holt, Tanya, Hruby, George, Pryor, David, Sidhom, Mark, Skala, Marketa, Yaxley, John and Shakespeare, Thomas P. (2019). Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group. Radiotherapy and Oncology, 140, 68-75. doi: 10.1016/j.radonc.2019.05.016

The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma

Raveenthiran, Sheliyan, Esler, Rachel, Yaxley, John and Kyle, Sam (2019). The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 46 (11), 2280-2288. doi: 10.1007/s00259-019-04432-2

Is the UICC/AJCC pT2 staging category for clear cell renal cell carcinoma meaningful?

Delahunt, Brett, Dagher, Julien, Egevad, Lars, Yaxley, John, Varma, Murali and Samaratunga, Hemamali (2019). Is the UICC/AJCC pT2 staging category for clear cell renal cell carcinoma meaningful?. American Journal of Surgical Pathology, 43 (9), 1249-1252. doi: 10.1097/PAS.0000000000001308

Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation

Srigley, John R., Delahunt, B., Samaratunga, Hemamali, Billis, Athanase, Cheng, L., Clouston, D., Evans, Andrew, Furusato, B., Kench, J., Leite, K., MacLennan, Gregory, Moch, Holger, Pan, Chin-Chen, Rioux-Leclercq, Nathalie, Ro, Jae, Shanks, Jonathan, Shen, Steven, Tsuzuki, Toyonori, Varma, Murali, Wheeler, Thomas, Yaxley, John and Egevad, Lars (2019). Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation. Pathology, 51 (5), 463-473. doi: 10.1016/j.pathol.2019.05.001

The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy

Raveenthiran, Sheliyan, Yaxley, John, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Tsang, Gail and MacKean, James (2019). The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy. Prostate Cancer and Prostatic Diseases, 22 (3), 385-390. doi: 10.1038/s41391-019-0163-0

Three-dimensional elastic augmented reality for robot-assisted laparoscopic prostatectomy: Pushing the boundaries, but cutting it fine

Pokorny, Morgan and Yaxley, John (2019). Three-dimensional elastic augmented reality for robot-assisted laparoscopic prostatectomy: Pushing the boundaries, but cutting it fine. European Urology, 76 (4), 515-516. doi: 10.1016/j.eururo.2019.04.025

Will favourable functional results with salvage robot-assisted laparoscopic radical prostatectomy increase the uptake of primary focal therapy for localised prostate cancer?

Yaxley, John W. (2019). Will favourable functional results with salvage robot-assisted laparoscopic radical prostatectomy increase the uptake of primary focal therapy for localised prostate cancer?. European Urology, 76 (1), 31-32. doi: 10.1016/j.eururo.2019.03.035

Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital

Donato, Peter, Morton, Andrew, Yaxley, John, Teloken, Patrick E., Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A. and Roberts, Matthew J. (2019). Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital. World Journal of Urology, 38 (2), 371-379. doi: 10.1007/s00345-019-02774-y

Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology

Yaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samartunga, Hemamali, Yaxley, Anna J., Coughlin, Geoff, Delahunt, Brett, Egevad, Lars, McEwan, Louise and Wong, David (2019). Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology. The Journal of Urology, 201 (4), 815-820. doi: 10.1097/JU.0000000000000053

Evolution, controversies and the future of prostate cancer grading

Egevad, Lars, Delahunt, Brett, Yaxley, John and Samaratunga, Hemamali (2019). Evolution, controversies and the future of prostate cancer grading. Pathology International, 69 (2), 55-66. doi: 10.1111/pin.12761

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Srigley, John R., Billis, Athanase, Bostwick, David G., Camparo, Philippe, Cheng, Liang, Clouston, David, Denham, James, Furusato, Bungo, Hartmann, Arndt, Jufe, Laura, Kench, James, Kenwright, Diane N., Kristiansen, Glen, Leite, Katia R.M., MacLennan, Gregory T., Merrimen, Jennifer, Moch, Holger, Oxley, Jon, Pan, Chin-Chen, Paner, Gladell, Ro, Jae, Sesterhenn, Isabell A. M., Shanks, Jonathan, Thunders, Michelle, Tsuzuki, Toyonori, Wheeler, Thomas ... Varma, Murali (2019). Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology, 52 (2), 192-196. doi: 10.1016/j.pathol.2019.11.001

Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology

Donato, Peter, Roberts, Matthew J., Morton, Andrew, Kyle, Samuel, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A. and Yaxley, John (2019). Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. European Journal of Nuclear Medicine and Molecular Imaging, 46 (1), 20-30. doi: 10.1007/s00259-018-4160-7

Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer

Yaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samaratunga, Hemamali, Yaxley, William J., Coughlin, Geoff, Yaxley, Anna J., Gianduzzo, Troy, Kua, Boon, McEwan, Louise and Wong, David (2019). Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer. BJU International, 124 (3), 401-407. doi: 10.1111/bju.14828

Brachytherapy-based radiotherapy with androgen deprivation for management of high-risk prostate cancer - time to reverse the declining trend?

Ong, Wee Loon, Yaxley, John W. and Millar, Jeremy L. (2018). Brachytherapy-based radiotherapy with androgen deprivation for management of high-risk prostate cancer - time to reverse the declining trend?. BJU International, 122 (S5), 5-6. doi: 10.1111/bju.14487

The current status of renal cell carcinoma and prostate carcinoma grading

Delahunt, Brett, Egevad, Lars, Yaxley, John and Samaratunga, Hemamali (2018). The current status of renal cell carcinoma and prostate carcinoma grading. International Braz J Urol, 44 (6), 1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01

Drugs for benign prostatic hypertrophy

Jiwrajka, Manasi, Yaxley, William, Ranasinghe, Sachinka, Perera, Marlon, Roberts, Matthew J. and Yaxley, John (2018). Drugs for benign prostatic hypertrophy. Australian Prescriber, 41 (5), 150-153. doi: 10.18773/austprescr.2018.045

MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature

Pokorny, Morgan, Kua, Boon, Esler, Rachel, Yaxley, John, Samaratunga, Hemamali, Dunglison, Nigel, Gianduzzo, Troy, Coughlin, Geoff, Holt, Ross, Laing, Barbara, Ault, Darren, Brown, Nicholas, Parkinson, Rob and Thompson, Les (2018). MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature. World Journal of Urology, 37 (7), 1263-1279. doi: 10.1007/s00345-018-2497-y

Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction

Koo, Kevin M., Wang, Jing, Richards, Renée S., Farrell, Aine, Yaxley, John W., Samaratunga, Hema, Teloken, Patrick E., Roberts, Matthew J., Coughlin, Geoffrey D., Lavin, Martin F., Mainwaring, Paul N., Wang, Yuling, Gardiner, Robert A. and Trau, Matt (2018). Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction. ACS Nano, 12 (8), 8362-8371. doi: 10.1021/acsnano.8b03698

Radiotherapy for recurrent prostate cancer: 2018 recommendations of the Australian and New Zealand radiation oncology genito-urinary group

Lieng, Hester, Hayden, Amy J., Christie, David R. H., Davis, Brian J., Eade, Thomas N., Emmett, Louise, Holt, Tanya, Hruby, George, Pryor, David, Shakespeare, Thomas P., Sidhom, Mark, Skala, Marketa, Wiltshire, Kirsty, Yaxley, John and Kneebone, Andrew (2018). Radiotherapy for recurrent prostate cancer: 2018 recommendations of the Australian and New Zealand radiation oncology genito-urinary group. Radiotherapy & Oncology, 129 (2), 377-386. doi: 10.1016/j.radonc.2018.06.027

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study

Coughlin, Geoffrey D., Yaxley, John W., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Teloken, Patrick, Dunglison, Nigel, Williams, Scott, Lavin, Martin F. and Gardiner, Robert A. (2018). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. The Lancet Oncology, 19 (8), 1051-1060. doi: 10.1016/S1470-2045(18)30357-7

Review and update of benign prostatic hyperplasia in general practice

Jiwrajka, Manasi, Yaxley, William, Perera, Marlon, Roberts, Matt, Dunglison, Nigel, Yaxley, John and Esler, Rachel (2018). Review and update of benign prostatic hyperplasia in general practice. Australian Journal of General Practice, 47 (7), 471-475. doi: 10.31128/AFP-08-17-4292

A novel technique for biobanking of large sections of radical prostatectomy specimens

Lindh, Claes, Delahunt, Brett, Samaratunga, Hemamali, Yaxley, John, Gudjónsdóttir, Jóna, Clements, Mark, Lindberg, Johan and Egevad, Lars (2018). A novel technique for biobanking of large sections of radical prostatectomy specimens. Histopathology, 72 (3), 481-489. doi: 10.1111/his.13386

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

Yaxley, J. W., Dagher, J., Delahunt, B., Egevad, L., Srigley, J. and Samaratunga, H. (2018). Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques. World Journal of Urology, 36 (1), 15-20. doi: 10.1007/s00345-017-2119-0

Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging–Reporting and Data System (PI-RADS) 3–5 MRI lesions

Yaxley, Anna J., Yaxley, John W., Thangasamy, Isaac A., Ballard, Emma and Pokorny, Morgan R. (2017). Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging–Reporting and Data System (PI-RADS) 3–5 MRI lesions. BJU International, 120 (S3), 43-50. doi: 10.1111/bju.13971

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases

Samaratunga, Hemamali, Delahunt, Brett, Srigley, John R., Yaxley, John, Johannsen, Shulammite, Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, Patterson, Imogen, Nacey, John N. and Egevad, Lars (2017). Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases. Histopathology, 71 (4), 641-647. doi: 10.1111/his.13278

Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading

Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Srigley, John R, Coughlin, Geoffrey, Dunglinson, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon, Yaxley, John and Samaratunga, Hemamali (2017). Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading. Histopathology, 71 (6), 918-925. doi: 10.1111/his.13311

Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

Yaxley, John W., Lah, Kevin, Yaxley, Julian P., Gardiner, Robert A., Samaratunga, Hema and MacKean, James (2017). Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years. BJU International, 120 (1), 56-60. doi: 10.1111/bju.13659

Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia

Gordon, Louisa G., James, Robbie, Tuffaha, Haitham W., Lowe, Anthony and Yaxley, John (2017). Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging, 45 (5), 1304-1315. doi: 10.1002/jmri.25504

Assessing robot-assisted laparoscopic prostatectomy - reply

Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Dunglison, Nigel and Gardiner, Robert A. (2017). Assessing robot-assisted laparoscopic prostatectomy - reply. Lancet, 389 (10071), 800-801. doi: 10.1016/S0140-6736(17)30508-1

Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation

Roberts, M.J., Richards, R.S., Chow, C.W.K., Buck, M., Yaxley, J., Lavin, M.F., Schirra, H.J. and Gardiner, R.A. (2017). Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation. Prostate International, 5 (4), 149-157. doi: 10.1016/j.prnil.2017.03.005

A cost-utility analysis of prostate cancer screening in Australia

Keller, Andrew, Gericke, Christian, Whitty, Jennifer A., Yaxley, John, Kua, Boon, Coughlin, Geoff and Gianduzzo, Troy (2016). A cost-utility analysis of prostate cancer screening in Australia. Applied Health Economics and Health Policy, 15 (1), 1-17. doi: 10.1007/s40258-016-0278-6

One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading

Srigley, John R., Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Yaxley, John and Evans, Andrew J. (2016). One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading. Canadian Urological Association Journal, 10 (9-10), 339-341. doi: 10.5489/cuaj.4146

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna, Lavin, Martin F. and Gardiner, Robert A. (2016). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet, 388 (10049), 1057-1066. doi: 10.1016/S0140-6736(16)30592-X

Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol

Roberts, Matthew J., Yaxley, John W., Coughlin, Geoffrey D., Gianduzzo, Troy R. J., Esler, Rachel C., Dunglison, Nigel T., Chambers, Suzanne K., Medcraft, Robyn J., Chow, Clement W. K., Schirra, Horst Joachim, Richards, Renee S., Kienzle, Nicholas, Lu, Macy, Brereton, Ian, Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Oyama, Chikara, Doi, Suhail A., Lavin, Martin F. and Gardiner, Robert A. (2016). Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol. Contemporary Clinical Trials, 50, 16-20. doi: 10.1016/j.cct.2016.06.014

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John, Srigley, John R. and Egevad, Lars (2016). From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. Scandinavian Journal of Urology, 50 (5), 325-329. doi: 10.1080/21681805.2016.1201858

Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers

Roberts, Matthew J., Richards, Renee S., Chow, Clement W. K., Doi, Suhail A. R., Schirra, Horst Joachim, Buck, Marion, Samaratunga, Hemamali, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2016). Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International, 4 (3), 97-102. doi: 10.1016/j.prnil.2016.04.002

A randomised control trial of salvage radiotherapy and androgen deprivation therapy following prostatectomy: commentary on five year follow-up findings

Williams, Scott, Yaxley, John W., Coughlin, Geoffrey D. and Gardiner, Robert A. (2016). A randomised control trial of salvage radiotherapy and androgen deprivation therapy following prostatectomy: commentary on five year follow-up findings. Translational Andrology and Urology, 5 (6), 971-973. doi: 10.21037/tau.2016.11.15

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer

Samaratunga, Hemamali, Delahunt, Brett, Gianduzzo, Troy, Coughlin, Geoff, Duffy, David, LeFevre, Ian, Johannsen, Shulammite, Egevad, Lars and Yaxley, John (2015). The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer. Pathology, 47 (6), 515-519. doi: 10.1097/PAT.0000000000000315

Long-term Survival Outcomes for Men Who Provided Ejaculate Specimens for Prostate Cancer Research: Implications for Patient Management

Ashrafi, Darius, Baade, Peter, Yaxley, John, Roberts, Matthew J., Williams, Scott and Gardiner, Robert A. (2015). Long-term Survival Outcomes for Men Who Provided Ejaculate Specimens for Prostate Cancer Research: Implications for Patient Management. European Urology Focus, 1 (2), 200-206. doi: 10.1016/j.euf.2015.04.002

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

Roberts, Matthew J., Chow, Clement W., Schirra, Horst J., Richards, Renee, Buck, Marion, Selth, Luke A., Doi, Suhail A. R., Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate, 75 (5), 539-549. doi: 10.1002/pros.22942

Changing status of investigations for prostate cancer detection

Gordon, Lachlan A. N., Yaxley, John, Frydenberg, Mark, Williams, Scott G and Gardiner, Robert A. (2015). Changing status of investigations for prostate cancer detection. Cancer Forum, 39 (3), 164-168.

Patients who receive androgen deprivation therapy risk adverse cognitive changes

Gardiner, Robert A., Yaxley, John, Pakenham, Kenneth I., Green, Heather, Mactaggart, Peter, Watson, Roger, Swanson, Cheryl and Nicol, David L. (2015). Patients who receive androgen deprivation therapy risk adverse cognitive changes. Journal of Clinical Oncology, 27 (9), 1-2. doi: 10.1200/JCO.2015.63.5698

A progress report on a prospective randomised trial of open and robotic prostatectomy

Gardiner, Robert A., Coughlin, Geoffrey D., Yaxley, John W., Dunglison, Nigel T., Occhipinti, Stefano, Younie, Sandra J., Carter, Rob C., Williams, Scott G., Medcraft, Robyn J., Samaratunga, Hema M., Perry-Keene, Joanna L., Payton, Diane J., Lavin, Martin F. and Chambers, Suzanne K. (2014). A progress report on a prospective randomised trial of open and robotic prostatectomy. European Urology, 65 (3), 512-515. doi: 10.1016/j.eururo.2013.10.031

Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men

Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John, Perry-Keene, Joanna, Lamb, David S., Srigley, John R., Egevad, Lars and Nacey, John N. (2014). Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men. Pathology, 46 (1), 11-14. doi: 10.1097/PAT.0000000000000044

Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness

Lose, Felicity, Batra, Jyotsna, O'Mara, Tracy, Fahey, Paul, Marquart, Louise, Eeeles, Ros A., Easton, Douglas F., Olama, Ali Amin Al, Kote-Jarai, Zsofia, Guy, Michelle, Muir, Kenneth, Lophatananon, Artitaya, Rahman, Aneela A., Neal, David E., Hamdy, Freddie C., Donovan, Jenny L., Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne F., Yaxley, John, Alexander, Kimberly, Clements, Judith A., Spurdle, Amanda B., Kedda, Mary-Anne and Australian Prostate Cancer BioResearch (2013). Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Urologic Oncology: Seminars and Original Investigations, 31 (5), 635-643. doi: 10.1016/j.urolonc.2011.05.011

Multifocal abscesses due to multiresistant Escherichia coli after trans rectal ultrasound-guided prostate biopsy

Roberts, Matthew J., Parambi, Anisha, Barrett, Lucinda, Hadway, Paul, Gardiner, Robert A. (Frank), Hajkowicz, Krispin M. and Yaxley, John (2013). Multifocal abscesses due to multiresistant Escherichia coli after trans rectal ultrasound-guided prostate biopsy. Medical Journal of Australia, 198 (5), 282-284. doi: 10.5694/mja12.11719

Prostate cancer: active surveillance as a management option

Yaxley, Julian, Yaxley, John, Gardiner, Robert and Yaxley, William (2013). Prostate cancer: active surveillance as a management option. Australian Family Physician, 42 (1), 74-76.

Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia

Baade, Peter D., Youlden, Danny R., Gardiner, Robert A., Ferguson, Megan, Aitken, Joanne F., Yaxley, John and Chambers, Suzanne K. (2012). Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia. BJU International, 110 (11b), E712-E719. doi: 10.1111/j.1464-410X.2012.011533.x

Integrating disparate snippets of information in an approach to PSA testing in Australia and New Zealand

Gardiner, Robert ('Frank') A., Yaxley, John and Baade, Peter D. (2012). Integrating disparate snippets of information in an approach to PSA testing in Australia and New Zealand. BJU International, 110 (S4), 35-37. doi: 10.1111/j.1464-410X.2012.11616.x

A randomised trial of robotic and open prostatectomy in men with localised prostate cancer

Gardiner, Robert A., Yaxley, John, Coughlin, Geoff, Dunglison, Nigel, Occhipinti, Stefano, Younie, Sandra, Carter, Rob, Williams, Scott, Medcraft, Robyn J., Bennett, Nigel, Lavin, Martin F. and Chambers, Suzanne Kathleen (2012). A randomised trial of robotic and open prostatectomy in men with localised prostate cancer. BMC Cancer, 12 (1) 189, 189.1-189.6. doi: 10.1186/1471-2407-12-189

Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study

Baade, Peter D., Gardiner, Robert A., Ferguson, Megan, Youlden, Danny R., Aitken, Joanne F., Yaxley, John and Chambers, Suzanne K. (2012). Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study. Cancer Causes and Control, 23 (4), 625-634. doi: 10.1007/s10552-012-9931-z

A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population

Batra, Jyotsna, Lose, Felicity, Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne, Yaxley, John, Clements, Judith A. and Spurdle, Amanda B. (2011). A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population. American Journal of Epidemiology, 174 (12), 1391-1395. doi: 10.1093/aje/kwr271

Association between prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in australia and a meta-analysis of GWAS data

Batra, Jyotsna, Lose, Felicity, O'Mara, Tracy, Marquart, Louise, Stephens, Carson, Alexander, Kimberly, Srinivasan, Srilakshmi, Eeles, Rosalind A., Easton, Douglas F., Olama, Ali Amin Al, Kote-Jarai, Zsofia, Guy, Michelle, Muir, Kenneth, Lophatananon, Artitaya, Rahman, Aneela A, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L., Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne, Yaxley, John, Kedda, Mary-Anne, Clements, Judith A. and Spurdle, Amanda B. (2011). Association between prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in australia and a meta-analysis of GWAS data. PLoS One, 6 (11) e26527, e26527-1-e26527-8. doi: 10.1371/journal.pone.0026527

Dosimetric effect of external beam planning preceding combined high-dose-rate brachytherapy of the prostate

Martin, Jarad M., Brett, Richard, Blyth, Jemma, Morrison, Stewart, Bryant, Daniel, Plank, Ashley, Cheuk, Robyn, Fay, Michael, Dickie, Graeme and Yaxley, John (2011). Dosimetric effect of external beam planning preceding combined high-dose-rate brachytherapy of the prostate. Brachytherapy, 10 (6), 474-478. doi: 10.1016/j.brachy.2010.10.003

Ductal adenocarcinoma of the prostate-reply

Samaratunga, Hemamali, Yaxley, John and Delahunt, Brett (2011). Ductal adenocarcinoma of the prostate-reply. Human Pathology, 42 (4), 606-607. doi: 10.1016/j.humpath.2010.07.026

Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases

Comperat, Eva, Roupret, Morgan, Yaxley, John, Reynolds, Jamie, Varinot, Justine, Ouzaid, Idir, Cussenot, Olivier and Samaratunga, Hemamali (2010). Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology, 42 (7), 650-654. doi: 10.3109/00313025.2010.522173

Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration

Samaratunga, Hemamali, Samaratunga, Dinithi, Perry-Keene, Joanna, Adamson, Michael, Yaxley, John and Delahunt, Brett (2010). Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration. Pathology, 42 (4), 330-333. doi: 10.3109/00313021003767330

Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension

Samaratunga, Hemamali, Duffy, David, Yaxley, John and Delahunt, Brett (2010). Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension. Human Pathology, 41 (2), 281-285. doi: 10.1016/j.humpath.2009.08.010

Significance of minute focus of adenocarcinoma on prostate needle biopsy

Samaratunga, Hemamali, Yaxley, John, Kerr, Kris, McClymont, Kelly and Duffy, David (2007). Significance of minute focus of adenocarcinoma on prostate needle biopsy. Urology, 70 (2), 299-302. doi: 10.1016/j.urology.2007.03.068

PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility

Lai, John, Kedda, Mary-Anne, Hinze, Kimberley, Smith, Robert L. G., Yaxley, John, Spurdle, Amanda B., Morris, C. Phillip, Harris, Jonathan and Clements, Judith A. (2007). PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis, 28 (5), 1032-1039. doi: 10.1093/carcin/bgl236

Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance

Samaratunga, H., Gardiner, R.A., Yaxley, J. and Brown, I. (2006). Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance. Analytical And Quantitative Cytology And Histology, 28 (2), 104-110.

A prospective study of the use of alternative therapies by men with localized prostate cancer

Steginga, S. K., Occhipinti, S., Gardiner, R. A., Yaxley, J. and Heathcote, P. (2004). A prospective study of the use of alternative therapies by men with localized prostate cancer. Patient Education And Counseling, 55 (1), 70-77. doi: 10.1016/j.pec.2003.07.007

Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer

Steginga, S.K., Occhipinti, S., Gardiner, R.A., Yaxley, J. and Heathcote, P. (2004). Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology, 63 (4), 751-756. doi: 10.1016/j.urology.2003.11.017

Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial

Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C. E., Watson, R. B. and Gardiner, R. A. (2004). Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU International, 93 (7), 975-979. doi: 10.1111/j.1464-410X.2004.04763.x

Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer M. M. Cherrier, A. L. Rose and C. Higano - J Urol, 170 : 1808-1811, 2003

Gardiner, R. A., Nicol, D. L., Green, H. J., Yaxley, J., Watson, R., Mactaggart, P., Headley, B. C., Swanson, C. and Pakenham, K. I. (2004). Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer M. M. Cherrier, A. L. Rose and C. Higano - J Urol, 170 : 1808-1811, 2003. Journal of Urology, 172 (2), 774-774. doi: 10.1097/01.ju.0000132508.20023.08

Altered Cognitive Function in Men Treated for Prostate Cancer with LHRH Analogues and Cyproterone Acetate: A Randomised Controlled Trial

Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C., Watson, R. B. and Gardiner, R. A. (2002). Altered Cognitive Function in Men Treated for Prostate Cancer with LHRH Analogues and Cyproterone Acetate: A Randomised Controlled Trial. British Journal of Urology BJU: International, 90 (4), 427-432. doi: 10.1046/j.1464-410X.2002.02917.x

Making decisions about treatment for localized prostate cancer

Steginga, S.K., Occhipinti, S., Gardiner, R. A., Yaxley, J. and Heathcote, P. (2002). Making decisions about treatment for localized prostate cancer. BJU International, 89 (3), 255-260. doi: 10.1046/j.1464-4096.2001.01741.x

The supportive care needs of men with prostate cancer (2000)

Steginga, S. K., Occhipinti, S., Dunn, J., Gardiner, R. A., Heathcote, P. and Yaxley, J. (2001). The supportive care needs of men with prostate cancer (2000). Psycho-oncology, 10 (1), 66-75. doi: 10.1002/1099-1611(200101/02)10:1<66::AID-PON493>3.0.CO;2-Z

Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men

Clements, J. A., Merritt, T., DeVoss, K., Swanson, C. E., Hamlyn, L., Scells, B., Rohde, P., Lavin, M. F., Yaxley, J. and Gardiner, R. A. (2000). Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men. BJU International, 86 (4), 453-458. doi: 10.1046/j.1464-410X.2000.00835.x

Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer

Munns, J., Yaxley, J., Coomer, J., Lavin, M.F., Gardiner, R.A. and Watters, D. (1998). Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer. British Journal of Urology, 82 (2), 284-289. doi: 10.1046/j.1464-410X.1998.00736.x

68 Ga-PSMA PET/CT findings in biochemical recurrence following primary radiation treatment for prostate cancer

Franklin, A. and Yaxley, J. (2020). 68 Ga-PSMA PET/CT findings in biochemical recurrence following primary radiation treatment for prostate cancer. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Analysis of national trends in the management of benign prostatic hyperplasia in Australia: updated population-based data

Chung, E., Teloken, P., Yaxley, J., Morton, A., Williams, M., Donato, P., Perera, M., Ranasinghe, S., Bolton, D. and Roberts, M. (2020). Analysis of national trends in the management of benign prostatic hyperplasia in Australia: updated population-based data. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Ga-68-PSMA PET/CT better predicts localisation of prostate cancer than 3T multiparametric MRI in men with PIRADS 3-5 abnormalities - correlation with histology at radical prostatectomy

Raveenthiran, S., Yaxley, W., Donato, P., Coughlin, G., Kua, B., Gianduzzo, T., Wong, D., Samaratunga, H. and Yaxley, J. (2020). Ga-68-PSMA PET/CT better predicts localisation of prostate cancer than 3T multiparametric MRI in men with PIRADS 3-5 abnormalities - correlation with histology at radical prostatectomy. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Ga-68-PSMA PET/CT outperforms mpMRI at intra-prostatic tumour characterisation following biopsy: should Ga-68-PSMA PET/CT be included earlier in the prostate cancer pathway?

Donato, P., Raveenthiran, S., Roberts, M., Yaxley, W., Morton, A., Ranasinghe, S., Teloken, P., Kyle, S., Pokorny, M., Coughlin, G., Esler, R., Dunglison, N., Gardiner, R. A., Kua, B., Gianduzzo, T. and Yaxley, J. (2020). Ga-68-PSMA PET/CT outperforms mpMRI at intra-prostatic tumour characterisation following biopsy: should Ga-68-PSMA PET/CT be included earlier in the prostate cancer pathway?. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Morbidity and cost implications of shifting from routine transrectal ultrasound-guided prostate biopsy to mpMRI triage with selective transperineal prostate biopsy: A 12-year retrospective analysis from a tertiary referral centre

Roberts, M., Macdonald, A., Teloken, P., Ranasinghe, S., Bennett, H., Gardiner, R., Dunglison, N., Esler, R. and Yaxley, J. (2020). Morbidity and cost implications of shifting from routine transrectal ultrasound-guided prostate biopsy to mpMRI triage with selective transperineal prostate biopsy: A 12-year retrospective analysis from a tertiary referral centre. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

NanoKnife focal therapy in Queensland: The first twelve months

Franklin, A., Oxford-Webb, R., Gianduzzo, T., Kua, B. and Yaxley, J. (2020). NanoKnife focal therapy in Queensland: The first twelve months. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Solitary rib lesions with PSMA uptake in prostate cancer patients - benign or malignant?

Chen, M., McBean, R., Tatkovic, A., McEwan, L., Walters, J., Wong, D., Yaxley, J., Gianduzzo, T. and Kua, B. (2020). Solitary rib lesions with PSMA uptake in prostate cancer patients - benign or malignant?. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

A Rare Case of Unclassified Prostate Cancer

Loganathan, Ajanthan, Lam, Tommy, Wong, Michelle, Perera, Marlon and Yaxley, John (2018). A Rare Case of Unclassified Prostate Cancer. ANZUP Annual Scientific Meeting - Putting People First, Sydney, NSW Australia, 8–10 July 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

"Age Migration" and decreased use of pelvic lymphadenectomy more than radical prostatectomy over 15 years

Joshi, A., Bolton, D., Yaxley, J., Perera, M., Roberts, M., Lawrentschuk, N., Papa, N., Ranasinghe, S. and Scott, S. (2018). "Age Migration" and decreased use of pelvic lymphadenectomy more than radical prostatectomy over 15 years. 71st Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Melbourne, Australia, 24-27 February 2018 . Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD

Nair-Shalliker, V., Rodge, J., Woo, H., Yaxley, J., Rasiah, K., Patel, M., Gillatt, D., Frydenberg, M., Malouf, D., Ende, D., Mancuso, P., Kimlin,, Gardiner, R., Gebski, V., Fenech, M., Smith, D. and Gurney, H. (2018). A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD. ANZUP Annual Scientific Meeting: Putting People First, Sydney, Australia, 8-10 July 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

A prostate tumor with unusual characteristics masquerading as a prostatic abscess

Loganathan, Ajanthan, Lam, Tommy, Wong, Michelle, Perera, Marlon and Yaxley, John (2018). A prostate tumor with unusual characteristics masquerading as a prostatic abscess. 19th Asia-Pacific Prostate Cancer Conference, Brisbane, Australia, 22-25 August 2018 . Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

An investigation using molecular and metabolomic biomarkers for the non-invasive detection and characterisation of prostate cancer

Chow, C., Schirra, H., Yaxley, J., Lavin, M., Roberts, M., Richards, R. and Gardiner, R. (2018). An investigation using molecular and metabolomic biomarkers for the non-invasive detection and characterisation of prostate cancer. 71st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Melbourne Australia, 24-27 February 2018. Hoboken, NJ United States: Wiley.

PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases

Scott, Susan E., Gianduzzo, Troy, Coughlin, Geoff, Kua, Boon, Parkinson, Rob, Samaratunga, Hemamali and Yaxley, John (2017). PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases. ANZUP Annual Scientific Meeting - The Art & Science of Best Practice, Melbourne, VIC Australia, 16–18 July 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Pelvic lymphadenectomy and radical prostatectomy in the elderly: inverse trends observed in Australian population data

Scott, Susan, Papa, Nathan, Roberts, Matthew, Perera, Marlon, Ranasinghe, Sachinka, Bolton, Damien, Lawrentschuk, Nathan and Yaxley, John (2017). Pelvic lymphadenectomy and radical prostatectomy in the elderly: inverse trends observed in Australian population data. ANZUP Annual Scientific Meeting - The Art & Science of Best Practice, Melbourne, VIC Australia, 16–18 July 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Infectious complications after TRUS biopsy in the era of antimicrobial resistance: a retrospective analysis considering trimethoprim and transperineal biopsy

Ranasinghe, Sachinka, Bennett, Harrison, Yaxley, John, Roberts, Matthew and Esler, Rachel (2017). Infectious complications after TRUS biopsy in the era of antimicrobial resistance: a retrospective analysis considering trimethoprim and transperineal biopsy. ANZUP Annual Scientific Meeting: The Art & Science of Best Practice, Melbourne, Australia, 16-18 July 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Non-invasive selection and monitoring of active surveillance candidates using NMR-based metabolomics: a preliminary investigation of seminal plasma

Roberts, Matthew J., Richards, Renee S. Stirling, Chow, Clement W., Buck, Marion, Yaxley, John W., Lavin, Martin F., Schirra, Horst Joachim J. and Gardiner, Robert ('Frank') (2017). Non-invasive selection and monitoring of active surveillance candidates using NMR-based metabolomics: a preliminary investigation of seminal plasma. ANZUP Annual Scientific Meeting: The Art & Science of Best Practice, Melbourne, Australia, 16-18 July 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell .

Trial based cost analysis of robot assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy

Younie, S., Gardiner, R., Mudiyanselage, S., Gao, L., Carter, R., Chambers, S., Yaxley, J., Coughlin, G., Occhipinti, S. and Dunglison, N. (2017). Trial based cost analysis of robot assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, Australia, 24-27 February 2017 . Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

A Randomized Controlled Trial of Robotic Versus Open Radical Prostatectomy: Early Outcomes

Gardiner, Robert ('Frank'), Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zaidlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna and Lavin, Martin F. (2016). A Randomized Controlled Trial of Robotic Versus Open Radical Prostatectomy: Early Outcomes. ANZUP Annual Scientific Meeting, GU Cancer: Expanding our Horizons, Brisbane, Australia, 10-12 July 2016. West Sussex, United Kingdom: Wiley. doi: 10.1111/ajco.12557

A new prostate-based biofluid for the detection of prostate cancer and diagnostic performance comparison using mRNA biomarkers

Roberts, M., Chow, C., Schirra, H., Richards, R., Buck, M., Doi, S., Samaratunga, H., Yaxley, J., Lavin, M. and Gardiner, R. (2016). A new prostate-based biofluid for the detection of prostate cancer and diagnostic performance comparison using mRNA biomarkers. 69th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, Gold Coast, Australia, 16-19 April 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/bju.13452

Development of navigate: an online treatment decision aid for men diagnosed with low risk prostate cancer

Schofield, Penelope, Hyatt, Amelia, Chambers, Suzanne K., Cavedon, Lawrence, White, Alan, Frydenberg, Mark, Murphy, Declan, Brooker, Joanne, Gardiner, Frank, Gordon, Louisa, Coughlin, Geoffrey, Millar, Jeremy, Grummet, Jeremy, Yaxley, John, Lawrentschuk, Nathan and Juraskova, Ilona (2016). Development of navigate: an online treatment decision aid for men diagnosed with low risk prostate cancer. 17th Asia-Pacific Prostate Cancer Conference, Melbourne Australia, August 31 - September 3, 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components; a clinicopathological analysis of 81 cases

Hemamali, Samaratunga, Delahunt, Brett, Egevad, Lars, Yaxley, John, Johannsen, Shulammite, Coughlin, Geoff and Gianduzzo, Troy (2016). Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components; a clinicopathological analysis of 81 cases. 105th Annual Meeting of the United States and Canadian Academy of Pathology, Seattle, Washington, 12-18 March 2016 . London, United Kingdom: Nature Publishing Group.

Prostatic fluid mRNA and microRNA biomarkers: an emerging paradigm for noninvasive diagnosis of prostate cancer

Roberts, Matthew J., Richards, R., Chow, C. W. K., Schirra, H., Buck, M., Selth, L. A., Doi, S. A., Samaratunga, H., Perry-Keene, J., Payton, D., Yaxley, J., Lavin, M. F. and Gardiner, R. A. (2016). Prostatic fluid mRNA and microRNA biomarkers: an emerging paradigm for noninvasive diagnosis of prostate cancer. ANZUP Annual Scientific Meeting, GU Cancer: Expanding our Horizons, Brisbane, QLD Australia, 10-12 July 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12558

The relative cost-effectiveness of MRI-prostate and TRUS for identification of significant prostate cancer in Australia

Keller, A., Gericke, C., Whitty, J., Yaxley, J., Kua, B., Coughlin, G. and Gianduzzo, T. (2016). The relative cost-effectiveness of MRI-prostate and TRUS for identification of significant prostate cancer in Australia. 69th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Gold Coast, QLD Australia, 16-19 April 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

A cost utility analysis of prostate cancer screening and surveillance in Australia

Gianduzzo, Troy, Keller, Andrew, Gericke, Christian, Whitty, Jennifer A., Kua, Boon, Yaxley, John and Coughlin, Geoff (2015). A cost utility analysis of prostate cancer screening and surveillance in Australia. 2nd Prostate Cancer World Congress (PCWC), Cairns, QLD Australia, 17-21 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

A cost utility analysis of prostate cancer screening in Australia

Keller, A., Gericke, C., Whitty, J., Yaxley, J., Kua, B., Coughlin, G. and Gianduzzo, T. (2015). A cost utility analysis of prostate cancer screening in Australia. 68th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13072

Long term survival outcomes for men who provided ejaculate specimens for prostate cancer research: implications for patient management

Ashrafi, D., Baade, P., Yaxley, J., Roberts, M., Williams, S. and Gardiner, R. A. (Frank) (2015). Long term survival outcomes for men who provided ejaculate specimens for prostate cancer research: implications for patient management. USANZ 2015: 68th Annual Scientific Meeting including 20th Annual Meeting of the Australia and New Zealand Urological Nurses Society, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

True false negative of MRI scans for prostate cancer screening. How often does MRI miss?

Scott, S., Samaratunga, H., Yaxley, J., Gianduzzo, T., Kua, B., Coughlin, G. and Breckenridge, M. (2015). True false negative of MRI scans for prostate cancer screening. How often does MRI miss?. 68th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/bju.13072

Prostate needle biopsy is predictive of neurovascular bundle involvement in radical prostatectomy

Samaratunga, H., Yaxley, J. and Delahunt, B. (2014). Prostate needle biopsy is predictive of neurovascular bundle involvement in radical prostatectomy. 103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), San Diego United States, Mar 01-07, 2014. London United Kingdom: Nature Publishing Group. doi: 10.1038/labinvest.2014.23

Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial

Gardiner, R. A., Mactaggart, P., Yaxley, J., Nicol, D., McClintock, S., Ellem, K. A. O., Hart, D., Seymour, G. J., Lopez, A. and Schmidt, C. (2014). Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial. ANZUP Annual Scientific Meeting, Melbourme, VIC Australia, 13-15 July 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12223_5

Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial

Gardiner, R. A., Mactaggart, P., Yaxley, J., Nicol, D., McClintock, S., Ellem, K., Hart, D., Seymour, G. J., Lopez, A. and Schmidt, C. (2014). Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD Australia, 16-19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

A Randomised Open and Robotic Prostatectomy: Trial Methodology

Gardiner, R. A., Coughlin, G., Yaxley, J., Dunglison, N., Occhipinti, S., Younie, S., Carter, R., Williams, S., Lavin, M. and Chambers, S. K. (2013). A Randomised Open and Robotic Prostatectomy: Trial Methodology. ANZUP Annual Scientific Meeting Advancing genitourinary cancer care through research and collaboration, Gold Coast, QLD Australia, 14 - 16 July 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/ajco.12098_4

Factors associated with diagnostic and treatment intervals and the treatment received by prostate cancer patients in Queensland

Baade, Peter D., Youlden, Danny R., Gardiner, Robert A., Ferguson, Megan, Aitken, Joanne F., Yaxley, John and Chambers, Suzanne K. (2012). Factors associated with diagnostic and treatment intervals and the treatment received by prostate cancer patients in Queensland. The Joint Meeting of the COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho–Oncology, Brisbane Australia, 13-15 November 2012. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12030

Immunohistochemical Expression of Prostate-Specific Antigen (PSA), Prostatic Acid Phosphatase (PAP) and Antibody Cocktail (P63/HMWCK/AMACR) in Ductal Adenocarcinoma of the Prostate

Samaratunga, H., Adamson, M., Yaxley, J. and Delahunt, B. (2011). Immunohistochemical Expression of Prostate-Specific Antigen (PSA), Prostatic Acid Phosphatase (PAP) and Antibody Cocktail (P63/HMWCK/AMACR) in Ductal Adenocarcinoma of the Prostate. 100th Annual Meeting of the United States and Canadian-Academy-of-Pathology, San Antonio Tx, Feb 26-Mar 04, 2011. NEW YORK: NATURE PUBLISHING GROUP.

Multiple markers in prediction of prostate cancer from ejaculate

Gardiner, R. A., Buck, M., Teng, L., Schirra, H. J., Roberts, M. J., Zenzmaier, C., Hancock, J., O'Rourke, P., Samaratunga, M. L. T. H., Scells, B., Payton, J. D., Perry-Keene, J., Yaxley, J., Coughlin, G. and Lavin, M. F. (2011). Multiple markers in prediction of prostate cancer from ejaculate. 20th Annual RBWH Health Care Symposium: Personalised Health Care, Brisbane, Australia, 10 -14 October 2011.

Multiple markers in prostate cancer detection from ejaculate

Gardiner, R. A., Teng, L., Buck, M., Hancock, J., Clarke, R., Samaratunga, H., Schirra, H. J., Zenzmaier, C., Berger, P., Catto, J., Yaxley, J., Gianduzzo, T., Coughlin, G. and Lavin, M. F. (2011). Multiple markers in prostate cancer detection from ejaculate. 64th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Christchurch, New Zealand, 21-24 February 2011. Oxford, U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2011.9997.x

Seminal Vesicle Sampling in Radical Prostatectomy Specimens

Samaratunga, H., Perry-Keene, J., Samaratunga, D., Adamson, M., Yaxley, J. and Delahunt, B. (2010). Seminal Vesicle Sampling in Radical Prostatectomy Specimens. 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington Dc, Mar 20-26, 2010. NEW YORK: NATURE PUBLISHING GROUP.

Molecular and metabonomic profiling of ejaculate fluid in prostate cancer detection

Teng, L., Buck, M., Scells, B., Clarke, R. A., Samaratunga, M. L. T. H., Yaxley, J., Gianduzzo, T., Coughlin, G., Lavin, M. F. and Gardiner, R. A. (2010). Molecular and metabonomic profiling of ejaculate fluid in prostate cancer detection. 63rd Annual Meeting of the Urological Society of Australia and New Zealand, Perth, Australia, 21-24 February 2010. Oxford, U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2010.09122.x

Multiple markers in prostate cancer detection in ejaculate

Teng, L., Buck, M., Hancock, J., Clarke, R., Samaratunga, H., Schirra, H., Zenzmaier, C., Berger, P., Catto, J., Yaxley, J., Gianduzzo, T., Coughlin, G., Lavin, M. and Gardiner, R. (2010). Multiple markers in prostate cancer detection in ejaculate. URS, USANZ Meeting 2010, Nelson, New Zealand, 10-12 November, 2010.

A Phase I vaccine study with metastatic tumour as the antigen source in patients with advanced castrate-resistant prostate cancer

Gardiner, R. A., Schmidt, C., Ellem, K. A. O., Lopez, A., Scells, B., O'Connor, L., Nicol, D. L., McClintock, P. and Yaxley, J. (2009). A Phase I vaccine study with metastatic tumour as the antigen source in patients with advanced castrate-resistant prostate cancer. 62nd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Gold Coast Australia, Mar 08-12, 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Molecular profiling of prostatic fluid in prostate cancer detection

Teng, L., Buck, M., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Lavin, M. F. and Gardiner, R. A. (2009). Molecular profiling of prostatic fluid in prostate cancer detection. 62nd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Gold Coast Australia, Mar 08-12, 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy

Samaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2009). Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy. 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Boston, MA, United States, Mar 07-13, 2009. NEW YORK: NATURE PUBLISHING GROUP.

A randomised controlled study of a DC-based vaccine study in patients with hormone escaping prostate cancer

Gardiner, R. A., Schmidtt, C., Ellem, K. A. O., Hart, D., Seymour, G. J., Lopez, A., Scells, B., O'Connor, L., Nicol, D. L., Mactaggart, P., Mcclintock, P. and Yaxley, J. (2008). A randomised controlled study of a DC-based vaccine study in patients with hormone escaping prostate cancer. 61st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Hong Kong Peoples R China, Feb 24-28, 2008. OXFORD: BLACKWELL PUBLISHING.

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

Samaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver Co, Mar 01-07, 2008. NEW YORK: NATURE PUBLISHING GROUP.

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

Samaratunga, H., Delahun, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver CO, United States, Mar 01-07, 2008. London, United Kingdom: Nature Publishing Group.

Any proportion of ductal adenocarcinoma of the prostate predicts higher stage disease

Samaratunga, H., Delahunt, B., Duffy, D., Brown, I. and Yaxley, J. (2008). Any proportion of ductal adenocarcinoma of the prostate predicts higher stage disease. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver, CO, United States, 1-7 March 2008. Amsterdam, Netherlands: Elsevier.

Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid

Gardiner, R. A., Burger, M. J., Landers, K. A., Roper, K., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Stening, S. and Lavin, M. F. (2007). Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid. Urological Society of Australia and New Zealand 60th Annual Scientific Meeting, Adelaide, Australia, 18-22 February 2007. London, UK: Blackwell Science. doi: 10.1111/j.1464-410X.2007.06719.x

A novel approach to decision support for men diagnosed with prostate cancer: The proscan study

Steginga, S. K., Clutton, S., Gardiner, R. A., Nicol, D. L., Heathcote, P., James, T., Wood, G. and Yaxley, J. (2006). A novel approach to decision support for men diagnosed with prostate cancer: The proscan study. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_1.x

Positive margin rates in patients with a single positive core on extended TRUS biopsy

Dangerfield, D., Samaratunga, H. and Yaxley, J. (2006). Positive margin rates in patients with a single positive core on extended TRUS biopsy. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Prostate biopsy: Common practices and differences amongst Australian and New Zealand urologists

Rao, R., Thomas, B., Dunglison, N., Gardiner, R. A., Yaxley, J., Peters, J. and Costello, A. (2006). Prostate biopsy: Common practices and differences amongst Australian and New Zealand urologists. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_5.x

Prostate cancer : Molecular diagnosis from prostatic fluid

Burger, M. J., Landers, K. A., Roper, K., Samaratunga, M. L. T. H., Yaxley, J., Stening, S., Lavin, M. F. and Gardiner, R. A. (2006). Prostate cancer : Molecular diagnosis from prostatic fluid. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_17.x

Prostrate cancer: molecular diagnosis from prostatic fluid

Burger, M. J., Landers, K. A., Roper, K., Samaratunga, M. L. T. H., Yaxley, J., Stening, S., Lavin, M. F. and Gardiner, R. A. (2006). Prostrate cancer: molecular diagnosis from prostatic fluid. Urological Society of Australasia Annual Scientific Meeting, Brisbane, Australia, 26‐30 March 2006. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_18.x

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy

Samaratunga, H, Yaxley, J, Kerr, K and McClymont, K (2006). The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy. 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Atlanta, Georgia, 11-17 February 2006 . London, United Kingdom: Nature Publishing Group.

Cognition and hormonal manipulation in prostate cancer

Green, H., Yaxley, J., Nicol, D. L., Headley, B. C., Pagenham, K., Mactaggart, P. N., Watson, R. B., Swanson, C. and Gardiner, R. A. (2001). Cognition and hormonal manipulation in prostate cancer. 2001 Annual Scientific Meeting of the Urological Society of Australasia, Coolum, QLD Australia, March 2001. Richmond, VIC Australia: Wiley-Blackwell.

Quality of Life Compared During Pharmacological Treatments and Clinical Monitoring for Non-Localised Prostate Cancer: A Randomised Controlled Trial

Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C., Watson, R. B. and Gardiner, R. A. (2003). Quality of Life Compared During Pharmacological Treatments and Clinical Monitoring for Non-Localised Prostate Cancer: A Randomised Controlled Trial.